These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

618 related articles for article (PubMed ID: 31510042)

  • 1. Intracerebral Injection of Extracellular Vesicles from Mesenchymal Stem Cells Exerts Reduced Aβ Plaque Burden in Early Stages of a Preclinical Model of Alzheimer's Disease.
    Elia CA; Tamborini M; Rasile M; Desiato G; Marchetti S; Swuec P; Mazzitelli S; Clemente F; Anselmo A; Matteoli M; Malosio ML; Coco S
    Cells; 2019 Sep; 8(9):. PubMed ID: 31510042
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Mesenchymal stem cells-derived extracellular vesicles ameliorate Alzheimer's disease in rat models via the microRNA-29c-3p/BACE1 axis and the Wnt/β-catenin pathway.
    Sha S; Shen X; Cao Y; Qu L
    Aging (Albany NY); 2021 Jun; 13(11):15285-15306. PubMed ID: 34086603
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Mesenchymal stem cell-derived extracellular vesicles ameliorate Alzheimer's disease-like phenotypes in a preclinical mouse model.
    Cone AS; Yuan X; Sun L; Duke LC; Vreones MP; Carrier AN; Kenyon SM; Carver SR; Benthem SD; Stimmell AC; Moseley SC; Hike D; Grant SC; Wilber AA; Olcese JM; Meckes DG
    Theranostics; 2021; 11(17):8129-8142. PubMed ID: 34373732
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Mesenchymal Stem Cell-Derived Extracellular Vesicles Suppresses iNOS Expression and Ameliorates Neural Impairment in Alzheimer's Disease Mice.
    Wang SS; Jia J; Wang Z
    J Alzheimers Dis; 2018; 61(3):1005-1013. PubMed ID: 29254100
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Bone marrow-derived mesenchymal stem cells contribute to the reduction of amyloid-β deposits and the improvement of synaptic transmission in a mouse model of pre-dementia Alzheimer's disease.
    Bae JS; Jin HK; Lee JK; Richardson JC; Carter JE
    Curr Alzheimer Res; 2013 Jun; 10(5):524-31. PubMed ID: 23036020
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Soluble CCL5 derived from bone marrow-derived mesenchymal stem cells and activated by amyloid β ameliorates Alzheimer's disease in mice by recruiting bone marrow-induced microglia immune responses.
    Lee JK; Schuchman EH; Jin HK; Bae JS
    Stem Cells; 2012 Jul; 30(7):1544-55. PubMed ID: 22570192
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Intranasal delivery of mesenchymal stem cell-derived extracellular vesicles exerts immunomodulatory and neuroprotective effects in a 3xTg model of Alzheimer's disease.
    Losurdo M; Pedrazzoli M; D'Agostino C; Elia CA; Massenzio F; Lonati E; Mauri M; Rizzi L; Molteni L; Bresciani E; Dander E; D'Amico G; Bulbarelli A; Torsello A; Matteoli M; Buffelli M; Coco S
    Stem Cells Transl Med; 2020 Sep; 9(9):1068-1084. PubMed ID: 32496649
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Extracellular Vesicles of Mesenchymal Stromal Cells Can be Taken Up by Microglial Cells and Partially Prevent the Stimulation Induced by β-amyloid.
    Kaniowska D; Wenk K; Rademacher P; Weiss R; Fabian C; Schulz I; Guthardt M; Lange F; Greiser S; Schmidt M; Braumann UD; Emmrich F; Koehl U; Jaimes Y
    Stem Cell Rev Rep; 2022 Mar; 18(3):1113-1126. PubMed ID: 35080744
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Endothelial cell-derived extracellular vesicles modulate the therapeutic efficacy of mesenchymal stem cells through IDH2/TET pathway in ARDS.
    Wu X; Tang Y; Lu X; Liu Y; Liu X; Sun Q; Wang L; Huang W; Liu A; Liu L; Chao J; Zhang X; Qiu H
    Cell Commun Signal; 2024 May; 22(1):293. PubMed ID: 38802896
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Extracellular Vesicles from Mesenchymal Stem Cells Exert Pleiotropic Effects on Amyloid-β, Inflammation, and Regeneration: A Spark of Hope for Alzheimer's Disease from Tiny Structures?
    Elia CA; Losurdo M; Malosio ML; Coco S
    Bioessays; 2019 Apr; 41(4):e1800199. PubMed ID: 30919493
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Distinct Effects of the Hippocampal Transplantation of Neural and Mesenchymal Stem Cells in a Transgenic Model of Alzheimer's Disease.
    Campos HC; Ribeiro DE; Hashiguchi D; Hukuda DY; Gimenes C; Romariz SAA; Ye Q; Tang Y; Ulrich H; Longo BM
    Stem Cell Rev Rep; 2022 Feb; 18(2):781-791. PubMed ID: 34997526
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Feasibility and Efficacy of Intra-Arterial Administration of Embryonic Stem Cell Derived-Mesenchymal Stem Cells in Animal Model of Alzheimer's Disease.
    Kim DY; Choi SH; Lee JS; Kim HJ; Kim HN; Lee JE; Shin JY; Lee PH
    J Alzheimers Dis; 2020; 76(4):1281-1296. PubMed ID: 32597802
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Intracerebral transplantation of bone marrow-derived mesenchymal stem cells reduces amyloid-beta deposition and rescues memory deficits in Alzheimer's disease mice by modulation of immune responses.
    Lee JK; Jin HK; Endo S; Schuchman EH; Carter JE; Bae JS
    Stem Cells; 2010 Feb; 28(2):329-43. PubMed ID: 20014009
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Soluble Aβ levels correlate with cognitive deficits in the 12-month-old APPswe/PS1dE9 mouse model of Alzheimer's disease.
    Zhang W; Hao J; Liu R; Zhang Z; Lei G; Su C; Miao J; Li Z
    Behav Brain Res; 2011 Sep; 222(2):342-50. PubMed ID: 21513747
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Mesenchymal stem cell-derived extracellular vesicles attenuate pulmonary vascular permeability and lung injury induced by hemorrhagic shock and trauma.
    Potter DR; Miyazawa BY; Gibb SL; Deng X; Togaratti PP; Croze RH; Srivastava AK; Trivedi A; Matthay M; Holcomb JB; Schreiber MA; Pati S
    J Trauma Acute Care Surg; 2018 Feb; 84(2):245-256. PubMed ID: 29251710
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Potential application of extracellular vesicles of human adipose tissue-derived mesenchymal stem cells in Alzheimer's disease therapeutics.
    Katsuda T; Oki K; Ochiya T
    Methods Mol Biol; 2015; 1212():171-81. PubMed ID: 25085563
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Human bone marrow mesenchymal stem cell-derived extracellular vesicles attenuate neuroinflammation evoked by focal brain injury in rats.
    Dabrowska S; Andrzejewska A; Strzemecki D; Muraca M; Janowski M; Lukomska B
    J Neuroinflammation; 2019 Nov; 16(1):216. PubMed ID: 31722731
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Graft-Versus-Host Disease Amelioration by Human Bone Marrow Mesenchymal Stromal/Stem Cell-Derived Extracellular Vesicles Is Associated with Peripheral Preservation of Naive T Cell Populations.
    Fujii S; Miura Y; Fujishiro A; Shindo T; Shimazu Y; Hirai H; Tahara H; Takaori-Kondo A; Ichinohe T; Maekawa T
    Stem Cells; 2018 Mar; 36(3):434-445. PubMed ID: 29239062
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Administrations of human adult ischemia-tolerant mesenchymal stem cells and factors reduce amyloid beta pathology in a mouse model of Alzheimer's disease.
    Harach T; Jammes F; Muller C; Duthilleul N; Cheatham V; Zufferey V; Cheatham D; Lukasheva YA; Lasser T; Bolmont T
    Neurobiol Aging; 2017 Mar; 51():83-96. PubMed ID: 28056358
    [TBL] [Abstract][Full Text] [Related]  

  • 20. S14G-humanin improves cognitive deficits and reduces amyloid pathology in the middle-aged APPswe/PS1dE9 mice.
    Zhang W; Zhang W; Li Z; Hao J; Zhang Z; Liu L; Mao N; Miao J; Zhang L
    Pharmacol Biochem Behav; 2012 Jan; 100(3):361-9. PubMed ID: 21993310
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 31.